Dormotech Medical
Revolutionizing sleep health with an all-in-one, AI-driven diagnostics platform
Company Overview
Snapshot
Founded in January 2021 by Abed Nassir, Shimon Hayun, and Aharon Shapira, Dormotech Medical operates with 11–50 employees. The company has secured funding across three rounds from three investors, with G.O Innovation leading one of its early rounds. A significant milestone for the company was the FDA approval of its wireless Type 2 HST device in January 2024, which streams data in real-time.
Business overview
Dormotech Medical is a digital health company specializing in the monitoring and diagnosis of sleep disorders. The company offers an all-in-one, AI-driven diagnostics platform, DormoVision X, which provides real-time physiological data monitoring and sleep analysis. This platform aims to deliver the accuracy of in-lab studies with the convenience of at-home testing, leveraging patented technology and FDA clearance. Dormotech Medical serves the healthcare industry, including clinics, insurance companies, and healthcare providers, operating within the digital healthcare, medical devices, and IoT sectors.
Strategic signal
In January 2024, Dormotech Medical received FDA approval for its wireless Type 2 HST device, which streams data in real-time. This regulatory clearance is a critical validation of the company's technology and its potential to transform sleep disorder diagnostics, signaling readiness for broader market adoption and enhanced credibility within the medical community.
Company Intelligence Q&A
- When was Dormotech Medical founded and by whom?
- Dormotech Medical was founded in January 2021 by Abed Nassir, Shimon Hayun, and Aharon Shapira.
- What is Dormotech Medical's primary product?
- Dormotech Medical's primary product is DormoVision X, an AI-driven diagnostics platform designed for real-time physiological data monitoring and sleep analysis for sleep disorders.
- Has Dormotech Medical received any regulatory approvals for its products?
- Yes, in January 2024, Dormotech Medical received FDA approval for its wireless Type 2 HST device, which streams data in real-time.
- Which investors have participated in Dormotech Medical's funding rounds?
- Dormotech Medical has received funding from investors including Intempo Ventures. G.O Innovation led a funding round in January 2021.
- What standards does Dormotech Medical's device meet?
- The DormoVision X device meets the stringent standards set by the Centers for Medicare & Medicaid Services (CMS) and the American Association of Sleep Medicine (AASM).